Patents by Inventor Lorise C. Gahring

Lorise C. Gahring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6010854
    Abstract: A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.
    Type: Grant
    Filed: July 3, 1997
    Date of Patent: January 4, 2000
    Assignee: University of Utah Research Foundation
    Inventors: Scott W. Rogers, Lorise C. Gahring, Roy E. Twyman
  • Patent number: 5731410
    Abstract: A peptide containing 24 amino acid residues that binds to anti-neuronal-glutamate-receptor autoantibodies associated with Rasmussen's encephalitis and that blocks activation of the GluR3 subunit is described. Methods of making the peptide and treating Rasmussen's encephalitis are also disclosed. Autoantibodies to other glutamate receptor subunits are associated with paraneoplastic neurodegenerative disease, amyotrophic lateral sclerosis, and neurodegenerative disease of unknown diagnosis. Methods of screening patients and of monitoring patients being treated for these disorders and syndromes are further described.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: March 24, 1998
    Assignee: University of Utah Research Foundation
    Inventors: Scott W. Rogers, Lorise C. Gahring, Roy E. Twyman